Eli Lilly taps Cogstate as preferred provider
Eli Lilly and Company has chosen Cogstate as its preferred provider to support its Alzheimer’s disease platform.
Archives for May 17, 2017
PPD ups capacity at vaccine development lab
Pharmaceutical Product Development, LLC (PPD) has expanded its Richmond, Virginia-based vaccine sciences lab.
IFPMA launches Alliance to track drug firms' progress in the fight against ‘superbugs'.
Charity urges drug industry to consider supplier role in “superbug” spread
Drug manufacturers, retail pharmacies and regulators have a role to play in curbing antimicrobial resistance say campaigners urging industry to ensure their API suppliers are not part of the problem.
CEFIC: members will only sell GHB intermediate to legitimate industry users
Cefic has agreed to make sure its members only sell the intermediate gamma butyrolactone (GBL) to legitimate users to stop it being abused or used in “date rape” drug GHB.
Acurian: new consulting service provides 'continuum of support'
Acurian Inc. has launched a new consulting offering to help pharma sponsors throughout protocol design, enrollment, site planning, and budgeting.